Hyperthermia enhances tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in human cancer cells

International Journal of Hyperthermia

Volumn 22, Issue 8, 2006, Pages 713-728

  Yoo, Jinsang ^a   Kim, Hyeong Reh Choi ^b   Lee, Yong J ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Caspase 3; Caspase 8; Caspase 9; CX 1; Hyperthermia; PARP 1; TRAIL; TUNEL

Indexed keywords

CASPASE; DEATH RECEPTOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME BINDING; ENZYME KINETICS; FIBROBLAST; HUMAN; HUMAN CELL; HYPERTHERMIC THERAPY; IN VITRO STUDY; PANCREAS CARCINOMA; PROSTATE ADENOCARCINOMA;

ANIMALS; APOPTOSIS; BIOLOGICAL THERAPY; CASPASE 1; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; HUMANS; HYPERTHERMIA, INDUCED; POLY(ADP-RIBOSE) POLYMERASES; RATS; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECOMBINANT PROTEINS; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 33847372476     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.1080/02656730601074052     Document Type: Article

References (66)

1. Pitti, RM,.Marsters, SA,.Ruppert, S.,.Donahue, CJ,.Moore, A. and Ashkenazi, A. (1996) Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem, 271, pp. 12687-12690.
2. Degli-Esposti, MA,.Dougall, WC,.Smolak, PJ,.Waugh, JY,.Smith, CA and Goodwin, RG (1997) The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain. Immunity, 7, pp. 813-820.
3. Degli-Esposti, MA,.Smolak, PJ,.Walczak, H.,.Waugh, J.,.Huang, CP,.DuBose, RF,.Goodwin, RG and Smith, CA (1997) Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family. J Exp Med, 186, pp. 1165-1170.
4. Marsters, SA,.Sheridan, JP,.Pitti, RM,.Huang, A.,.Skubatch, M.,.Baldwin, D.,.Yuan, J.,.Gurney, A.,.Goddard, AD and Godowski, P. (1997) Identification of a ligand for the death-domain-containing receptor Apo3. Curr Biol, 7, pp. 1003-1006.
5. Pan, G.,.Wei, YF,.Gentz, R. and Dixit, VM (1997) An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science, 277, pp. 815-818.
6. Pan, G.,.O'Rourke, K.,.Chinnaiyan, AM,.Gentz, R.,.Ebner, R. and Dixit, VM (1997) The receptor for the cytotoxic ligand TRAIL. Science, 276, pp. 111-113.
7. Sheridan, JP,.Marsters, SA,.Pitti, RM,.Gurney, A.,.Skubatch, M.,.Baldwin, D.,.Ramakrishnan, L.,.Gray, CL,.Baker, K. and Wood, WI (1997) Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science, 277, pp. 818-821.
8. Walczak, H.,.Degli-Esposti, MA,.Johnson, RS,.Smolak, PJ,.Waugh, JY,.Boiani, N.,.Timour, MS,.Gerhart, MJ,.Schooley, KA and Smith, CA (1997) TRAIL-R2: A novel apoptosis-mediating receptor for TRAIL. EMBO J, 16, pp. 5386-5397.
9. Clancy, L.,.Mruk, K.,.Archer, K.,.Woelfel, M.,.Mongkolsapaya, J.,.Screaton, G.,.Lenardo, MJ and Chan, FK (2005) Preligand assembly domain-mediated ligand-independent association between TRAIL receptor 4 (TR4) and TR2 regulates TRAIL-induced apoptosis. Proc Natl Acad Sci USA, 102, pp. 18099-18104.
10. Ashkenazi, A. and Dixit, VM (1999) Apoptosis control by death and decoy receptors. Curr Opin Cell Biol, 11, pp. 255-260.
11. Gura, T. (1997) How TRAIL kills cancer cells, but not normal cells. Science, 277, p. 768.
12. Keane, MM,.Ettenberg, SA,.Nau, MM,.Russell, EK and Lipkowitz, S. (1999) Chemotherapy augments TRAIL-induced apoptosis in breast cell lines. Cancer Res, 59, pp. 734-741.
13. Griffith, TS,.Chin, WA,.Jackson, GC,.Lynch, DH and Kubin, MZ (1998) Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells. J Immunol, 161, pp. 2833-2840.
14. Sato, T.,.Irie, S.,.Kitada, S. and Reed, JC (1995) FAP-1: A protein tyrosine phosphatase that associates with Fas. Science, 268, pp. 411-415.
15. Wen, J.,.Ramadevi, N.,.Nguyen, D.,.Perkins, C.,.Worthington, E. and Bhalla, K. (2000) Antileukemic drugs increase death receptor 5 levels and enhance Apo-2L-induced apoptosis of human acute leukemia cells. Blood, 96, pp. 3900-3906.
16. Vassilev, A.,.Ozer, Z.,.Navara, C.,.Mahajan, S. and Uckun, FM (1999) Bruton's tyrosine kinase as an inhibitor of the Fas/CD95 death-inducing signaling complex. J Biol Chem, 274, pp. 1646-1656.
17. Tschopp, J.,.Martinon, F. and Hofmann, K. (1999) Apoptosis: Silencing the death receptors. Curr Biol, 9, pp. R381-R384.
18. Hitoshi, Y.,.Lorens, J.,.Kitada, SI,.Fisher, J.,.LaBarge, M.,.Ring, HZ,.Francke, U.,.Reed, JC,.Kinoshita, S. and Nolan, GP (1998) Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells. Immunity, 8, pp. 461-471.
19. Kothny-Wilkes, G.,.Kulms, D.,.Luger, TA,.Kubin, M. and Schwarz, T. (1999) Interleukin-1 protects transformed keratinocytes from tumor necrosis factor-related apoptosis-inducing ligand- and CD95-induced apoptosis but not from ultraviolet radiation-induced apoptosis. J Biol Chem, 274, pp. 28916-28921.
20. Deveraux, QL and Reed, JC (1999) IAP family proteins-suppressors of apoptosis. Genes Dev, 13, pp. 239-252.
21. Tamm, I.,.Wang, Y.,.Sausville, E.,.Scudiero, DA,.Vigna, N.,.Oltersdorf, T. and Reed, JC (1998) IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res, 58, pp. 5315-5320.
22. Ashkenazi, A.,.Pai, RC,.Fong, S.,.Leung, S.,.Lawrence, DA,.Marsters, SA,.Blackie, C.,.Chang, L.,.McMurtrey, AE and Hebert, A. (1999) Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest, 104, pp. 155-162.
23. Walczak, H.,.Miller, RE,.Ariail, K.,.Gliniak, B.,.Griffith, TS,.Kubin, M.,.Chin, W.,.Jones, J. and Woodward, A. (1999) Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nature Med, 5, pp. 157-163.
24. French, LE and Tschopp, J. (1999) The TRAIL to selective tumor death. Nature Med, 5, pp. 146-147.
25. Bouralexis, S.,.Findlay, DM,.Atkins, GJ,.Labrinidis, A.,.Hay, S. and Evdokiou, A. (2003) Progressive resistance of BTK-143 osteosarcoma cells to Apo2L/TRAIL-induced apoptosis is mediated by acquisition of DcR2/ TRAIL-R4 expression: Resensitisation with chemotherapy. Br J Cancer, 89, pp. 206-214.
26. Tillman, DM,.Izeradjene, K.,.Szucs, KS,.Douglas, L. and Houghton, JA (2003) Rottlerin sensitizes colon carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis via uncoupling of the mitochondria independent of protein kinase C. Cancer Res, 63, pp. 5118-5125.
27. Nagane, M.,.Pan, G.,.Weddle, JJ,.Dixit, VM,.Cavenee, WK and Huang, HJ (2000) Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo. Cancer Res, 60, pp. 847-853.
28. Lee, YJ,.Lee, KH,.Kim, HR,.Jessup, JM,.Seol, DW,.Kim, TH,.Billiar, TR and Song, YK (2001) Sodium nitroprusside enhances TRAIL-induced apoptosis via a mitochondria-dependent pathway in human colorectal carcinoma CX-1 cells. Oncogene, 20, pp. 1476-1485.
29. Fulda, S.,.Jeremias, I. and Debatin, KM (2004) Cooperation of betulinic acid and TRAIL to induce apoptosis in tumor cells. Oncogene, 23, pp. 7611-7620.
30. Chinnaiyan, AM,.Prasad, U.,.Shankar, S.,.Hamstra, DA,.Shanaiah, M.,.Chenevert, TL,.Ross, BD and Rehemtulla, A. (2000) Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy. Proc Natl Acad Sci USA, 97, pp. 1754-1759.
31. Park, SY,.Billiar, TR and Seol, DW (2002) IFN-gamma inhibition of TRAIL-induced IAP-2 upregulation, a possible mechanism of IFN-gamma-enhanced TRAIL-induced apoptosis. Biochem Biophys Res Comm, 291, pp. 233-236.
32. Nyormoi, O.,.Mills, L. and Bar-Eli, M. (2003) An MMP-2/MMP-9 inhibitor, 5a, enhances apoptosis induced by ligands of the TNF receptor superfamily in cancer cells. Cell Death Diff, 10, pp. 558-569.
33. Lee, YJ,.Song, JJ,.Kim, JH,.Kim, HR and Song, YK (2004) Low extracellular pH augments TRAIL-induced apoptotic death through the mitochondria-mediated caspase signal transduction pathway. Exp Cell Res, 293, pp. 129-143.
34. Nam, SY,.Amoscato, AA and Lee, YJ (2002) Low glucose-enhanced TRAIL cytotoxicity is mediated through the ceramide-Akt-FLIP pathway. Oncogene, 21, pp. 337-346.
35. Lee, YJ,.Froelich, CJ,.Fujita, N.,.Tsuruo, T. and Kim, JH (2004) Reconstitution of caspase-3 confers low glucose-enhanced tumor necrosis factor-related apoptosis-inducing ligand cytotoxicity and Akt cleavage. Clin Cancer Res, 10, pp. 1894-1900.
36. Lee, YJ,.Moon, MS,.Kwon, SJ and Rhee, JG (2005) Hypoxia and low glucose differentially augments TRAIL-induced apoptotic death. Mol Cell Biochem, 270, pp. 89-97.
37. Oleson, JR,.Calderwood, SK,.Coughlin, CT,.Dewhirst, MW,.Gerweck, LE,.Gibbs, FA and Kapp, DS (1988) Biological and clinical aspects of hyperthermia in cancer therapy. Am J Clin Oncol, 11, pp. 368-380.
38. Riehemann, K.,.Schmitt, O. and Ehlers, EM (2005) The effects of thermochemotherapy using cyclophosphamide plus hyperthermia on the malignant pleural mesothelioma in vivo. Ann Anat, 187, pp. 215-223.
39. Ohguri, T.,.Imada, H.,.Kato, F.,.Yahara, K.,.Morioka, T.,.Nakano, K. and Korogi, Y. (2006) Radiotherapy with 8MHz radiofrequency-capacitive regional hyperthermia for pain relief of unresectable and recurrent colorectal cancer. Int J Hyperthermia, 22, pp. 1-14.
40. van der Zee, J.,.Gonzalez, D Gonzalez,.van Rhoon, GC and van Dijk, JD (2000) Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: A prospective, randomized trial, Dutch Deep Hyperthermia Group. Lancet, 356, pp. 771-772.
41. Jones, EL,.Oleson, JR,.Prosnitz, LR,.Samulski, TV,.Vujaskovic, Z.,.Sanders, LL and Dewhirst, MW (2005) Randomize trial of hyperthermia and radiation for superficial tumors. J Clin Oncol, 23, pp. 3079-3085.
42. Issels, RD,.Prenninger, SW,.Nagele, A.,.Boehm, E.,.Sauer, H.,.Jauch, KW,.Denecke, H.,.Berger, H.,.Peter, K. and Wilmanns, W. (1990) Ifosfamide plus etoposide combined with regional hyperthermia in patients with locally advanced sarcomas: A phase II study. J Clin Oncol, 8, pp. 1818-1829.
43. Wendtner, CM,.Abdel-Rahman, S.,.Krych, M.,.Baumert, J.,.Lindner, LH,.Baur, A.,.Hiddemann, W. and Issels, RD (2002) Response to neoadjuvant chemotherapy combined with regional hyperthermia predicts long term survival for adult patients with retroperitoneal and visceral high-risk soft tissue sarcomas. J Clin Oncol, 20, pp. 3156-3164.
44. Kapp, DS,.Fressenden, P.,.Samulski, TV,.Bagshaw, MA,.Cox, RS,.Lee, ER,.Lohrbach, AW,.Meyer, JL and Prionas, SD (1988) Stanford University Institutional report. Phase I evalulation of hyperthermia equipment for hyperthermic treatment of cancer. Int J Hyperthermia, 4, pp. 75-116.
45. Sapozink, MD,.Gibbs, FA,.Gibbs, P. and Stewart, JR (1988) Phase I evaluation of hyperthermia equipment: University of Utah Institutional report. Int J Hyperthermia, 4, pp. 117-132.
46. Dewhirst, MW,.Vujaskovic, Z.,.Jones, E. and Thrall, D. (2005) Re-setting the biologic rationale for thermal therapy. Int J Hyperthermia, 21, pp. 779-790.
47. Burow, ME,.Weldon, CB,.Tang, Y.,.Navar, GL,.Krajewski, S.,.Reed, JC,.Hammond, TG,.Clejan, S. and Beckman, BS (1998) Differences in susceptibility to tumor necrosis factor alpha-induced apoptosis among MCF-7 breast cancer cell variants. Cancer Res, 58, pp. 4940-4946.
48. Laemmli, UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, pp. 680-685.
49. Cretney, E.,.Shanker, A.,.Yagita, H.,.Smyth, MJ and Sayers, TJ (2006) TNF-related apoptosis-inducing ligand as a therapeutic agent in autoimmunity and cancer. Immunol Cell Biol, 84, pp. 87-98.
50. Ryu, S.,.Brown, SL,.Kim, SH,.Khil, MS and Kim, JH (1996) Preferential radiosensitization of human prostatic carcinoma cells by mild hyperthermia. Int J Radiat Oncol Biol Phys, 34, pp. 133-138.
51. Raaphorst, GP,.Miao, J. and Ng, CE (1997) Cisplatin and mild hyperthermia in radiosensitization to low dose rate irradiation in human ovarian carcinoma cells. Anticancer Res, 17, pp. 3469-3472.
52. Atallah, D.,.Marsaud, V.,.Radanyi, C.,.Kornprobst, M.,.Rouzier, R.,.Elias, D. and Renoir, JM (2004) Thermal enhancement of oxaliplatin-induced inhibition of cell proliferation and cell cycle progression in human carcinoma cell lines. Int J Hyperthermia, 20, pp. 405-419.
53. Song, CW,.Park, HJ,.Lee, CK and Griffin, R. (2005) Implications of increased tumor blood flow and oxygenation caused by mild temperature hyperthermia in tumor treatment. Int J Hyperthermia, 21, pp. 761-767.
54. Srinivasan, JM,.Fajardo, LF and Hahn, GM (1990) Mechanism of antitumor activity of tumor necrosis factor alpha with hyperthermia in a tumor necrosis factor alpha-resistant tumor. J Natl Cancer Inst, 82, pp. 1904-1910.
55. Klostergaard, J.,.Leroux, E.,.Siddik, ZH,.Khodadadian, M. and Tomasovic, SP (1992) Enhanced sensitivity of human colon tumor cell lines in vitro in response to thermochemoimmunotherapy. Cancer Res, 52, pp. 5271-5277.
56. Lee, YJ,.Hou, Z.,.Curetty, L.,.Cho, JM and Corry, PM (1993) Synergistic effects of cytokine and hyperthermia on cytotoxicity in HT-29 cells are not mediated by alteration of induced protein levels. J Cell Physiol, 155, pp. 27-35.
57. Ozoren, N. and El-Deiry, W. (2002) Heat shock protects HCT116 and H460 cells from TRAIL-induced apoptosis. Exp Cell Res, 281, pp. 175-181.
58. Beere, HM,.Wolf, BB,.Cain, K.,.Mosser, DD,.Mahboubi, A.,.Kuwana, T.,.Tailor, P.,.Morimoto, RI,.Cohen, GM and Green, DR (2000) Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nature Cell Biol, 2, pp. 469-475.
59. Saleh, A.,.Srinivasula, SM,.Balkir, L.,.Robbins, PD and Alnemri, ES (2000) Negative regulation of the Apaf-1 apoptosome by Hsp70. Nat Cell Biol, 2, pp. 476-483.
60. Pandey, P.,.Saleh, A.,.Nakazawa, A.,.Kumar, S.,.Srinivasula, SM,.Kumar, V.,.Weichselbaum, R.,.Nalin, C.,.Alnemri, ES and Kufe, D. (2000) Negative regulation of cytochrome c-mediated oligomerization of Apaf-1 and activation of procaspase-9 by heat shock protein 90. EMBO J, 19, pp. 4310-4322.
61. Ran, R.,.Zhou, G.,.Zhang, L.,.Tang, Y.,.Rigby, AC and Sharp, FR (2004) Hsp70 mutant proteins modulate additional apoptotic pathways and improve cell survival. Cell Stress Chap, 9, pp. 229-242.
62. Ravagnan, L.,.Gurbuxani, S.,.Susin, SA,.Maisse, C.,.Daugas, E.,.Zamzami, N.,.Mak, T.,.Jaattela, M.,.Penninger, JM and Garrido, C. (2001) Heat-shock protein 70 antagonizes apoptosis-inducing factor. Nat Cell Biol, 3, pp. 839-843.
63. Sheikh, MS,.Burns, TF,.Huang, Y.,.Wu, GS,.Amundson, S.,.Brooks, KS,.Fornace Jr, AJ and el-Deiry, WS (1998) p53-dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor alpha. Cancer Res, 58, pp. 1593-1598.
64. Pastorino, JG,.Chen, ST,.Tafani, M.,.Snyder, JW and Farber, JL (1998) The overexpression of Bax produces cell death upon induction of the mitochondrial permeability transition. J Biol Chem, 273, pp. 7770-7775.
65. Yang, J.,.Liu, X.,.Bhalla, K.,.Kim, CN,.Ibrado, AM,.Cai, J.,.Peng, TI,.Jones, DP and Wang, X. (1997) Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science, 275, pp. 1129-1132.
66. Srinivasan, A.,.Wang, Y.,.Armstrong, RC,.Tomaselli, KJ and Fritz, LC (1997) Cell-specific induction of apoptosis by microinjection of cytochrome c. Bcl-xL has activity independent of cytochrome c release. J Biol Chem, 272, pp. 30299-30305.